News

Filter

Current filters:

Biotechnology

1 to 9 of 3760 results

EMA validates Biogen and AbbVie’s Zinbryta MAA for multiple sclerosis

27-03-2015

The European Medicines Agency has validated the Marketing Authorization Application for US biotech firms…

AbbVieBiogenBiotechnologydaclizumabEuropeNeurologicalRegulationZinbryta

Novasep to supply ingredient for Celladon’s Mydicar

Novasep to supply ingredient for Celladon’s Mydicar

26-03-2015

French active ingredients company Novasep and US biotech firm Celladon Corp, a clinical-stage cardiovascular…

BiotechnologyCardio-vascularCelladonMydicarNovasepProduction

BioNano Genomics appoints Terry Salyer as chief commercial officer

BioNano Genomics appoints Terry Salyer as chief commercial officer

26-03-2015

Genome mapping specialist BioNano Genomics has appointed Terry Salyer as chief commercial officer.

BioNano GenomicsBiotechnologyBoardroomTerry SalyerUSA

Green Cross and Nanolek enter strategic partnership to commercialize biologics in Russia

Green Cross and Nanolek enter strategic partnership to commercialize biologics in Russia

26-03-2015

South Korean biopharma company Green Cross and Russian drugmaker Nanolek have entered into a strategic…

BiotechnologyGreen CrossLicensingMarkets & MarketingNanolekRussia

FDA approves Eylea for diabetic retinopathy in patients with diabetic macular edema

FDA approves Eylea for diabetic retinopathy in patients with diabetic macular edema

25-03-2015

The US Food and Drug Administration today expanded the approved use for US biotech firm Regeneron’s…

BayerBiotechnologyDiabetesEyleaGenentechLucentisOphthalmicsRegeneron PharmaceuticalsRegulationUSA

Signum Dermalogix licenses SIG990 to Dermata Therapeutics for rosacea

Signum Dermalogix licenses SIG990 to Dermata Therapeutics for rosacea

25-03-2015

Dermatology biotech company Signum Dermalogix has entered into an agreement with Dermata Therapeutics…

BiotechnologyDermatologicalsLicensingResearchSignum Dermalogix

Semma Therapeutics secures $44 million funding to develop diabetes cell therapy

25-03-2015

USA-based biotech start-up Semma Therapeutics, which is developing a cell therapy for type 1 diabetes,…

BiotechnologyDiabetesFinancialNovartisResearchSemma Therapeutics

Lpath's Asonep fails to meet primary endpoint at Phase IIa; shares slide

Lpath's Asonep fails to meet primary endpoint at Phase IIa; shares slide

25-03-2015

Lpath says that its investigational therapy Asonep (sonepcizumab) did not meet the primary endpoint in…

AsonepBiotechnologyLpathOncologyResearch

1 to 9 of 3760 results

Back to top